Drug data last refreshed 11h ago · AI intelligence enriched 11h ago
PANDEL is a topical corticosteroid cream containing hydrocortisone probutate, a mid-potency steroid used to treat inflammatory skin conditions. It reduces inflammation and itching in dermatological indications through glucocorticoid receptor activation. The product is indicated for various inflammatory and pruritic dermatoses where topical corticosteroid therapy is appropriate.
As a mature topical corticosteroid approaching loss of exclusivity with minimal Part D spending, this product likely operates with a small, defensive commercial team focused on maintaining existing prescriber relationships.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on PANDEL offers limited career growth due to its mature, commoditized position in the crowded topical corticosteroid market. Roles on this product are primarily defensive in nature, focused on maintaining market share and managing generic competition rather than driving innovation or expansion.
Worked on PANDEL at ANI Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo